Document ID: FDA-2009-N-0360-0011
Agency: fda
Document Type: Notice
Title: Agency Information Collection Activities; Proposed Collection;
Comment Request; Food and Drug Administration Safety Communication Readership Survey; Withdrawal of Notice
Posted Date: 2020-04-16T04:00Z

[Federal Register Volume 85, Number 74 (Thursday, April 16, 2020)]
[Notices]
[Pages 21246-21247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08004]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0360]

Agency Information Collection Activities; Proposed Collection; 
Comment Request; Food and Drug Administration Safety Communication 
Readership Survey; Withdrawal of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of a notice that was published in the Federal Register of 
March 6, 2020.

DATES: The notice is withdrawn on April 16, 2020.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White

[[Page 21247]]

Flint North, 10A63, 11601 Landsdown St., North Bethesda, MD 20852, 301-
796-7726, PRAStaff@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In a notice published in the Federal 
Register of March 6, 2020 (85 FR 13171), ``Agency Information 
Collection Activities; Proposed Collection; Comment Request; Food and 
Drug Administration Safety Communication Readership Survey,'' FDA 
requested comment on the information collection associated with Safety 
Communication Readership Surveys.
    Under the Paperwork Reduction Act of 1995 (the PRA), Federal 
Agencies are required to publish notice in the Federal Register 
concerning each proposed collection of information, including each 
proposed extension of an existing collection of information, and to 
allow 60 days for public comment in response to the notice.
    In the March 6, 2020, Federal Register document, FDA proposed to 
extend the information collection related to the Safety Communication 
Readership Survey (OMB control number 0910-0341). However, we are 
withdrawing the notice because, upon further review of the information 
collection request (ICR), we have determined that it is more 
appropriate to include the estimated burden expressed in the Safety 
Communication Readership Survey ICR in the ``generic'' ICR for 
``Testing Communications on Medical Devices and Radiation-Emitting 
Products'' (OMB control number 0910-0678).
    Because we intend to submit information collections for safety 
communication readership surveys under the generic information 
collection approval, OMB control number 0910-0678, we will discontinue 
the ICR for OMB control number 0910-0341 and we are withdrawing the 
March 6, 2020, document requesting comment on the information 
collection.

    Dated: April 8, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-08004 Filed 4-15-20; 8:45 am]
 BILLING CODE 4164-01-P